Home › Funds › Silverberg Bernstein Capital Management LLC › NAGE

Silverberg Bernstein Capital Management LLC position in NAGE

NIAGEN BIOSCIENCE INC · Health Care

Silverberg Bernstein Capital Management LLC reported holding 137,952 shares of NAGE (NIAGEN BIOSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$403K, representing 0.19% of its reported portfolio and ranking #47 among its reported holdings. Silverberg Bernstein Capital Management LLC has disclosed NAGE holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)137.95K sh
Reported value held$402.82K
Portfolio Weight0.19%
First reportedQ4 2023
Last changeReduce
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Silverberg Bernstein Capital Management LLC's NAGE position evolved

Silverberg Bernstein Capital Management LLC first disclosed a stake in NAGE in Q4 2023 at 82,757 shares (US$118K). The position peaked in Q2 2025 at 99,476 shares, worth US$1.4M. Across 12 filings, Silverberg Bernstein Capital Management LLC increased the stake 7 time(s), trimmed it 3 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 137,952 shares valued at US$403K — a reduction of -2,650 shares quarter over quarter.. Notable position changes include a 26% increase in Q3 2025 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 82.76K $118.34K New
Q1 2024 82.16K $285.91K Reduce
Q2 2024 82.16K $224.29K Hold
Q3 2024 83.26K $303.89K Add
Q4 2024 80.54K $427.25K Reduce
Q1 2025 95.54K $659.21K Add
Q2 2025 99.48K $1.43M Add
Q3 2025 125.26K $1.17M Add
Q4 2025 131.16K $834.19K Add
Q1 2026 138.10K $609.03K Add
Q2 2026 140.60K $448.52K Add
Q3 2026 137.95K $402.82K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NAGE and 13F data

NAGE (NIAGEN BIOSCIENCE INC) is a Health Care company. 29 other funds we track also report a position in NAGE — the largest reported positions include Tieton Capital Management, LLC (US$6.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NAGE

All NAGE fund holders →

FAQ

How long has Silverberg Bernstein Capital Management LLC held NAGE?

Silverberg Bernstein Capital Management LLC has disclosed NAGE holdings in 12 of the last 12 reported quarters, going back to Q4 2023.

What is Silverberg Bernstein Capital Management LLC's current position in NAGE?

As of Q3 2026, Silverberg Bernstein Capital Management LLC holds 137.95K shares of NAGE (NIAGEN BIOSCIENCE INC), valued at $402.82K, representing 0.19% of its reported portfolio and ranking #47.

Has Silverberg Bernstein Capital Management LLC been buying or selling NAGE?

In the latest 13F filing (Q3 2026), Silverberg Bernstein Capital Management LLC reduced its position in NAGE. The position peaked in Q2 2025 at 99.48K shares.

Which other funds hold NAGE?

Other major institutional holders of NAGE include Tieton Capital Management, LLC, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.